男性女乳症手術市場－全球產業規模、佔有率、趨勢、機會和預測：按年齡層、手術類型、最終用途、地區和競爭格局分類，2021-2031年

全球男性女乳症手術市場預計將從 2025 年的 1.8 億美元成長到 2031 年的 2.9 億美元，複合年成長率為 8.54%。

這些療法旨在透過手術切除男性多餘的乳房和脂肪組織，從而恢復更平坦、更具男性特徵的胸部輪廓。推動這一市場發展的關鍵因素包括社會對男性美容治療的接受度不斷提高，以及男性對自身外觀和心理健康的日益關注。此外，藥物濫用和生活方式因素導致的荷爾蒙失衡現像日益普遍，也持續推動對矯正手術的穩定需求。

根據國際美容整形外科學會的數據，2023年全球共進行了352,302例男性女乳症手術。儘管數量龐大，但該市場在保險報銷政策方面仍面臨諸多障礙。大多數醫療機構將此類手術歸類為美容手術而非醫療必需手術，導致患者自付費用高昂，限制了患者的就醫途徑，並阻礙了市場的整體成長。

市場促進因素

社群媒體和名流文化對男性美學標準的日益影響，是全球男性女乳症手術市場的主要驅動力。男性經常接觸到推崇完美「V」型胸部的數位內容，這促使他們自我評估胸部輪廓，並增加他們透過手術矯正過度發育組織的願望。這種文化轉變正在減少男性接受整形手術的偏見，並擴大了選擇專業治療的男性群體，他們不僅出於醫療原因，也出於美觀方面的考慮。因此，國內的手術量依然保持強勁。根據美國美容整形外科學會2024年6月發布的報告，2023年美國共進行了21,043例男性女乳症手術，使其成為男性第二大最受歡迎的手術。

同時，可支配收入的成長以及人們在特定醫療項目上的消費意願也支撐著市場價值。儘管大多數保險政策將男性乳房縮小手術歸類為美容手術，並要求患者承擔全部費用，但該領域仍在持續成長，克服了這些經濟障礙。這一趨勢體現在手術費用的飆升上，這不僅反映了通貨膨脹的壓力，也顯示消費者對專業效果的重視。例如，美國整形外科醫師協會在2024年6月報告稱，該手術的平均費用已上漲至5,587美元。這種對美容計畫的投入反映了整個產業的韌性，正如美國美容整形外科學會2024年的報告所示，手術總數較去年同期成長2.9%。

市場挑戰

全球市場成長的一大障礙是，絕大多數保險公司將男性女乳症手術歸類為美容手術。醫療保險支付方通常不承認該手術的醫療必要性，保險理賠經常被拒，迫使患者自行承擔全部費用。這些費用不僅包括外科醫生的費用，還包括手術室費用和麻醉費用，構成了一道高昂的經濟門檻，實際上將許多患有此病卻無力承擔手術費用的患者拒之門外。

因此，這種限制性的保險報銷環境嚴重阻礙了患者對整形手術的濃厚興趣轉化為實際手術。儘管病例數增加，社會接受度也有所提高，但由於經濟限制導致患者難以獲得手術機會，市場擴張速度仍然緩慢。美國整形外科醫師協會的數據凸顯了這個問題，報告顯示，到2024年，男性女乳症縮小手術的數量預計僅增加2%。這一微弱的成長清楚地表明，保險支持的不足正在阻礙市場發展勢頭，並使該行業無法充分發揮其潛在需求。

市場趨勢

隨著越來越多的男性乳房增大手術從傳統醫院轉移到專業的門診中心，男性乳房增大市場格局正在重塑。這項轉變主要源自於病人對隱私和效率的需求，對於尋求更私密治療方式的男性而言，這兩點尤其重要。專業機構提供了一種高效的治療途徑，避免了普通醫院繁瑣的行政流程和高昂的運營成本，同時確保了高標準的安全性，並方便患者就診。美國美容外科協會（The Aesthetic Society）於2024年7月發布的數據也印證了這個趨勢。該數據顯示，2023年所有整形手術中有64%是在獲得認證的手術中心進行的，這表明手術模式正在明顯地從醫院轉向其他場所。

同時，隨著能量輔助抽脂技術逐漸取代傳統切除方法，臨床通訊協定也不斷發展。外科醫生正在採用射頻輔助和動力輔助溶脂等先進設備，這些設備具有高精度和減少疤痕的優點，可用於治療腺體和脂肪組織。與傳統手術刀技術不同，這些能量型系統能夠同時消脂並收縮皮膚，從而達到「緊緻塑形」的效果。這滿足了那些希望擁有優美胸型但又不想留下明顯手術疤痕的患者的需求。這項技術的引入推動了手術數量的成長。 AirSculpt Technologies公司在2024年2月的報告中指出，使用其專有的能量型塑形技術的手術量年增了14.3%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球男性女乳症手術市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依年齡層（18-40歲，40歲以上）
  • 依手術類型（抽脂、切除術）
  • 依最終用途（醫院、整形外科中心）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美男性女乳症手術市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲男性女乳症手術市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區男性女乳症手術市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲男性女乳症手術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲男性女乳症手術市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球男性女乳症手術市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Allergan Aesthetics
• Sientra
• Cynosure
• Cutera
• Galderma
• Heraeus
• Clarion Medical
• Mazor Robotics
• InMode

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Gynecomastia Procedures Market is projected to expand from a valuation of USD 0.18 Billion in 2025 to USD 0.29 Billion by 2031, reflecting a CAGR of 8.54%. These procedures entail the surgical reduction of excess glandular or fatty breast tissue in men, aiming to restore a flatter and more masculine chest profile. Key drivers propelling this market include broader societal acceptance of male aesthetic treatments and an intensified focus on physical appearance and mental well-being. Additionally, the rising prevalence of hormonal imbalances caused by medication use and lifestyle factors continues to fuel consistent demand for corrective interventions.

According to the International Society of Aesthetic Plastic Surgery, 352,302 gynecomastia procedures were performed globally in 2023. Despite this substantial volume, the market encounters a significant obstacle regarding insurance reimbursement policies. Most healthcare providers categorize this surgery as a cosmetic enhancement rather than a medical necessity, leading to steep out-of-pocket costs that restrict patient access and hinder overall market expansion.

Market Driver

The increasing influence of social media and celebrity culture on male beauty standards acts as a primary catalyst for the global gynecomastia procedures market. Men are frequently exposed to digital content that glorifies a sculpted, "V-taper" physique, which fosters critical self-assessment of chest contours and fuels the desire for surgical correction of overdeveloped tissue. This cultural shift has destigmatized male cosmetic interventions, prompting a broader demographic to pursue professional treatment for aesthetic improvements rather than solely medical reasons. Consequently, procedure volumes remain robust nationally, with The Aesthetic Society reporting in June 2024 that gynecomastia treatment became the second most popular surgical procedure for men in the U.S. during 2023, totaling 21,043 operations.

Simultaneously, rising disposable incomes and a willingness to spend on elective medical treatments are sustaining market value. Although most insurance policies classify male breast reduction as cosmetic, forcing patients to bear the full financial burden, the sector continues to thrive despite these economic barriers. This trend is reflected in escalating surgical costs, which signal both inflationary pressures and the premium consumers place on specialized results; for instance, the American Society of Plastic Surgeons noted in June 2024 that the average surgeon fee for this procedure rose to $5,587. This investment in aesthetic improvement mirrors broader industry resilience, as evidenced by The Aesthetic Society's 2024 report showing a 2.9 percent year-over-year increase in total surgical volume.

Market Challenge

A major barrier to the growth of the global market is the classification of gynecomastia surgery as a cosmetic enhancement by the majority of insurance providers. Since healthcare payers often deem this procedure not medically necessary, coverage applications are frequently denied, forcing patients to assume the full financial liability. This burden encompasses not only the surgeon's fee but also facility and anesthesia costs, creating a high economic threshold that effectively excludes a significant portion of the addressable population who suffer from the condition but cannot afford elective surgery.

Consequently, this restrictive reimbursement landscape severely limits the conversion of high patient interest into actual surgical volume. Despite the increasing incidence of the condition and greater social acceptance, the market struggles to expand rapidly as financial constraints hamper accessibility. Data from the American Society of Plastic Surgeons highlights this issue, reporting that gynecomastia reduction procedures increased by only 2% in 2024. This marginal growth rate clearly indicates that the lack of insurance support is stifling market momentum and preventing the industry from fully realizing the underlying demand.

Market Trends

The operational landscape of the gynecomastia market is being reshaped by a shift in surgical volumes from traditional hospitals to specialized ambulatory centers. This transition is largely driven by a demand for greater patient privacy and efficiency, which are crucial for the male demographic seeking discretion. Specialized facilities provide a streamlined care pathway that avoids the administrative burdens and high overhead costs of general hospitals, making the procedure more accessible while ensuring high safety standards. This preference is supported by data from The Aesthetic Society, which reported in July 2024 that 64% of all cosmetic surgical procedures in 2023 were performed in Accredited Surgical Centers, marking a distinct departure from hospital settings.

Concurrently, clinical protocols are evolving as energy-assisted liposuction technologies increasingly replace traditional excision methods. Surgeons are adopting advanced tools like radiofrequency-assisted or power-assisted lipolysis to treat glandular tissue and fat with superior precision and reduced scarring. Unlike standard scalpel-based techniques, these energy-based systems enable simultaneous fat removal and skin retraction, delivering a "shrink-wrapping" effect that appeals to patients wanting a sculpted chest without significant surgical marks. This technological adoption is driving volume growth, as demonstrated by AirSculpt Technologies' February 2024 report, which noted a 14.3% year-over-year increase in case volume attributed to their proprietary energy-based body contouring techniques.

Key Market Players

• Allergan Aesthetics
• Sientra
• Cynosure
• Cutera
• Galderma
• Heraeus
• Clarion Medical
• Mazor Robotics
• InMode

Report Scope

In this report, the Global Gynecomastia Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gynecomastia Procedures Market, By Age Group

• 18-40
• Above 40

Gynecomastia Procedures Market, By Procedure Type

• Liposuction
• Excision

Gynecomastia Procedures Market, By End-Use

• Hospitals
• Cosmetic Surgery Center

Gynecomastia Procedures Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gynecomastia Procedures Market.

Available Customizations:

Global Gynecomastia Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gynecomastia Procedures Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Age Group (18-40, Above 40)
  • 5.2.2. By Procedure Type (Liposuction, Excision)
  • 5.2.3. By End-Use (Hospitals, Cosmetic Surgery Center)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Gynecomastia Procedures Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Age Group
  • 6.2.2. By Procedure Type
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gynecomastia Procedures Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Age Group
      • 6.3.1.2.2. By Procedure Type
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Gynecomastia Procedures Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Age Group
      • 6.3.2.2.2. By Procedure Type
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Gynecomastia Procedures Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Age Group
      • 6.3.3.2.2. By Procedure Type
      • 6.3.3.2.3. By End-Use

7. Europe Gynecomastia Procedures Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Age Group
  • 7.2.2. By Procedure Type
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gynecomastia Procedures Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Age Group
      • 7.3.1.2.2. By Procedure Type
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Gynecomastia Procedures Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Age Group
      • 7.3.2.2.2. By Procedure Type
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Gynecomastia Procedures Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Age Group
      • 7.3.3.2.2. By Procedure Type
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Gynecomastia Procedures Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Age Group
      • 7.3.4.2.2. By Procedure Type
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Gynecomastia Procedures Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Age Group
      • 7.3.5.2.2. By Procedure Type
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Gynecomastia Procedures Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Age Group
  • 8.2.2. By Procedure Type
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gynecomastia Procedures Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Age Group
      • 8.3.1.2.2. By Procedure Type
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Gynecomastia Procedures Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Age Group
      • 8.3.2.2.2. By Procedure Type
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Gynecomastia Procedures Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Age Group
      • 8.3.3.2.2. By Procedure Type
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Gynecomastia Procedures Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Age Group
      • 8.3.4.2.2. By Procedure Type
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Gynecomastia Procedures Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Age Group
      • 8.3.5.2.2. By Procedure Type
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Gynecomastia Procedures Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Age Group
  • 9.2.2. By Procedure Type
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gynecomastia Procedures Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Age Group
      • 9.3.1.2.2. By Procedure Type
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Gynecomastia Procedures Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Age Group
      • 9.3.2.2.2. By Procedure Type
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Gynecomastia Procedures Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Age Group
      • 9.3.3.2.2. By Procedure Type
      • 9.3.3.2.3. By End-Use

10. South America Gynecomastia Procedures Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Age Group
  • 10.2.2. By Procedure Type
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gynecomastia Procedures Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Age Group
      • 10.3.1.2.2. By Procedure Type
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Gynecomastia Procedures Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Age Group
      • 10.3.2.2.2. By Procedure Type
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Gynecomastia Procedures Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Age Group
      • 10.3.3.2.2. By Procedure Type
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gynecomastia Procedures Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Allergan Aesthetics
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sientra
• 15.3. Cynosure
• 15.4. Cutera
• 15.5. Galderma
• 15.6. Heraeus
• 15.7. Clarion Medical
• 15.8. Mazor Robotics
• 15.9. InMode

16. Strategic Recommendations

17. About Us & Disclaimer